Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...
Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...
The contract research and development segment provides drug discovery and development ... status at the facility since receiving the warning letter in 2013.On 7 January 2016, Jubilant Biosys ...
Meanwhile, Tyche Industries was issued its warning letter on Feb. 6 following an inspection of the company's Kakinada manufacturing plant last August. The company previously received and responded ...
Next Science (ASX:NXS) shares fell -13% on Tuesday morning trades, to 10cps, after the company revealed it’s received a ...
James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...
The top official in charge of food safety and nutrition at the Food and Drug Administration resigned this week, protesting the dozens of scientists and other health officials now being let go ...
Regeneron Pharmaceuticals and Sanofi have won Food and Drug Administration priority review of their application seeking expanded approval of their blockbuster anti-inflammatory drug Dupixent for ...
The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...
Seeing the words "Class I food recall" might make you think of contaminated products sitting on grocery store shelves, but ...
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.
Sanofi and Regeneron’s Dupixent (dupilumab) has been accepted for priority review by the US Food and Drug Administration (FDA) to treat adults with bullous pemphigoid (BP). BP is a chronic and ...